Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

Condition:   Atopic Dermatitis Interventions:   Drug: PF-04965842 200 mg;   Drug: PF-04965842 100 mg;   Drug: Placebo Sponsor:   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials